Patent Board Rejects Edwards’ Heart Valve Claim-Review Request
The US Patent Office has rejected a request by Edwards Lifesciences to review an Abbott patent on heart-valve technology, which could establish the patent as a key part of Abbott Laboratories’ arguments in a larger ongoing intellectual property case.
You may also be interested in...
Edwards’ Pascal transcatheter mitral valve repair devices has been blocked from most use after being found to infringe on Abbott’s patents by a British court.
A Delaware court sided with Abbott over Edwards in a pretrial hearing on terminology to be used in a patent dispute concerning transcatheter mitral valve repair device technology.
Medicare coverage of innovative and life-saving devices, drugs and diagnostics were the focus of a 19 September Congressional hearing during which representatives pressed for swifter and more predictable paths to reimbursement.